Money3 share price sinks as COVID-19 squashes profits

The Money3 share price has sunk more than 7% today after the automotive lender released full year results below expectation

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Money3 Corporation Limited (ASX: MNY) share price has sunk more than 7% today after the automotive lender released full year results below expectation. A $10.1 million impairment provision related to COVID-19 weighed on profits despite strong loan book growth.

What does Money3 do? 

Money3 provides personal and automotive loans in Australia and New Zealand. Prior to the pandemic, the company was originating more than $1 million in loans every business day. Money3 had previously provided guidance for net profits after tax (NPAT) of around $30 million for FY20, but withdrew guidance in March due to the coronavirus pandemic. 

How did Money3 perform?

Money3 saw strong growth in the loan book in the first half of the financial year, but growth slowed significantly in the second half.

With consumers paying extra attention to budgeting due to the economic slowdown, many were wary of taking on new financial commitments such as car and personal loans. Loan originations were lower than expected as a result of COVID-19 and tightened lending criteria. Over the full year, the gross loan book grew 16.4% to $433.8 million. 

Revenue increased 35.3% to $124 million while earnings before interest, taxes, depreciation and amortisation (EBITDA) increased 31.1% to $60.7 million. Cash collections increased 36.3% to $277.2 million as customers made efforts to increase loan repayments in the face of uncertainty.

Money3 says the overall loan book quality and arrears performance has not deteriorated over 2020. Nonetheless, given increasing economic uncertainty as a result of COVID-19, the company has taken a $10.1 million non-cash economic outlook provision. 

Normalised NPAT increased 14.2% on the previous year to $32.3 million, but the impact of the COVID-19-related provision resulted in a statutory NPAT of $24.2 million. A final fully franked dividend of 3 cents per share was declared, taking the full year dividend to 8 cents per share.

Managing director Scott Baldwin said: "Through all the challenges the Group has faced, including COVID-19, we continued to grow, which is a testament to the team's deep knowledge of the industry and commitment to succeed." 

What's the outlook for Money3? 

The Money3 share price has been punished by investors today, but is still up 125% from its March low. Despite tightened lending criteria, Money3 saw a return in loan application volumes in June and July. This, along with reduced competition in the sector, leaves the team confident of seeing solid loan growth in the new financial year.

A strategic review of product offerings has resulted in an expansion in the near prime sector, broadening the addressable market. Expanding distribution should lead to solid organic growth in FY21 with Money3 confident of loan book growth exceeding $500 million. 

Motley Fool contributor Kate O'Brien has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on ASX Share Market News

An old-fashioned panel of judges each holding a card with the number 10
Share Gainers

Here are the top 10 ASX 200 shares today

It was one for the record books this Wednesday.

Read more »

Time to sell written on a clock.
Broker Notes

Sell alert! Why this expert is calling time on Magellan and Ramsay Health Care shares

A leading expert forecasts growing headwinds for Magellan and Ramsay Health Care shares. But why?

Read more »

A beautiful ocean vista is shown with a woman whose back is to the camera holding her arms up in triumph as she stands at the top of a rock feeling thrilled that ASX 200 shares are reaching multi-year high prices today
ASX Share Market News

Record breaker! The ASX 200 just hit a fresh all-time high

Investors just sent the ASX 200 into uncharted territory.

Read more »

Pilot on the phone looking distraught.
Broker Notes

Sell alert! Why this expert is ditching Qantas shares for this ASX 200 defence stock

A leading expert is selling Qantas shares and buying this surging ASX 200 defence stock instead. But why?

Read more »

An old-fashioned news boy stands on a stool and yells through a microphone in an open field.
ASX Share Market News

Why is everyone talking about Domino's, Light & Wonder and BHP shares on Wednesday?

BHP, Light & Wonder, and Domino’s shares are turning heads today. But why?

Read more »

Medical workers examine an x-ray or scan in a hospital laboratory.
Broker Notes

Up 64%, 3 reasons this expert predicts Pro Medicus shares will keep on giving

A leading expert forecasts more outperformance from the surging Pro Medicus share price.

Read more »

A woman leans forward with her hand behind her ear, as if trying to hear information.
ASX Share Market News

Earnings preview: can Cochlear shares rebound?

A decade low share price meets a make-or-break result.

Read more »

Business man marking buy on board and underlining it.
Broker Notes

Leading brokers name 3 ASX shares to buy today

Brokers believe that now could be the time to buy these shares.

Read more »